11 episodes

Answering questions around the pharmaceutical & biotechnology industry through podcast and social media

What The Pharma Unknown

    • Science

Answering questions around the pharmaceutical & biotechnology industry through podcast and social media

    Episode 11 - Opioid Epidemic

    Episode 11 - Opioid Epidemic

    In this episode, I cover the latest on Obamacare repeal (where the Republicans have pulled their repeal & replace plan), BPCIA lawsuits between Amgen v Genentech as well as Janssen v Celltrion, FDA approval of 23AndMe's first genentic test product, FDA approval times, and the general introduction to the current US Opioid Epidemic.

    • 16 min
    Episode 10 - Trumpcare Proposal

    Episode 10 - Trumpcare Proposal

    In this episode, I review the Trumpcare, or American Health Care Act, which is set to modify the PPACA established by Obama.  After outlining the proposed changes, I review what incentives remain for market players to act upon when the new system is enacted.

    • 20 min
    Episode 9 - Marathon pricing, Amgen v Sanofi updates, CRISPR lawsuit, and Editing baby genes

    Episode 9 - Marathon pricing, Amgen v Sanofi updates, CRISPR lawsuit, and Editing baby genes

    In this episode, I cover the recent issue with Marathon's pricing of a steriod drug for DMD, updates to Amgen v Sanofi and the new biosimilar lawsuit between Genentech v Amgen as well as the recent patent lawsuit around CRISPR technology between UC Berkeley and the Broad Institute.  We close the episode around the introduction of the new book, Human Genome Editing, and how authorities have provided green lights in different countries to alter baby-genes for therapeutic purposes.

    • 19 min
    Episode 8 - Trump's FDA deregulation proposal, 21st Century Cures Act, and Value-based Reimbursement Model

    Episode 8 - Trump's FDA deregulation proposal, 21st Century Cures Act, and Value-based Reimbursement Model

    In this episode, I open with the latest #GOBOLDY (read: Go Boldy, not GOB OLDY) campaign by the industry trade association, PhRMA, then move onto Trump's latest request to Pharma companies to lower prices, one solution of which is his proposal on lessening FDA regulations so drugs will enter into the market faster.  I then move onto the 21st Century Cures Act to clear up any potential confusion on where this Act modifies FDA approvals process as well as a high-level overview of the Act.  Then, I move onto what the pharma companies have proposed on lowering prices, which is through value-based reimbursement models.

    • 18 min
    Episode 7 - Science, PhRMA campaign and new discoveries and J&J's R&D productivity stop gap M&A

    Episode 7 - Science, PhRMA campaign and new discoveries and J&J's R&D productivity stop gap M&A

    In this episode, I discuss the new Pfizer campaign around scientists as well as Martin Shkreli's response to the Davos comments.  Then we discuss J&J's move to acquire Actelion and more importantly, their decision to spin off the R&D unit to be independent.  Near the end, discussion around scientific discoveries in the area of CAR-T treatment of two babies and new findings in breast cancer including drug resistance and passive/backseat genes that manipulate the cancer progression.

    • 17 min
    Episode 6 - Getting away with Murder? Reputation of Pharma & Future of R&D Productivity

    Episode 6 - Getting away with Murder? Reputation of Pharma & Future of R&D Productivity

    In this episode, I recap briefly heresay around the pharmaceutical industry from the new POTUS and a Pharma CEO then move onto updates around the repeal of PPACA then onto the solutions around R&D productivity in Pharma.

    • 20 min

Customer Reviews

Brofratbro ,

Fantastic content, entertaining and educational

Jeff does an incredible job bringing together science, facts, policy and entertainment. He brings a phenomenal educational and industry background to head in one place. A must-listen primer for anyone interested in the industry.

Top Podcasts In Science

Listeners Also Subscribed To